SR-12813 is primarily used in research settings for its ability to modulate cholesterol metabolism. It activates pathways involved in the degradation of HMG-CoA reductase, a key enzyme in cholesterol synthesis, making it a valuable tool for studying cellular cholesterol regulation. Due to this property, it has been used to investigate potential therapeutic strategies for hypercholesterolemia and related cardiovascular diseases. Additionally, SR-12813 serves as a reference compound in biochemical assays focused on sterol regulatory element-binding proteins (SREBPs) and their role in lipid homeostasis. Its use remains confined to laboratory and preclinical research, aiding in the development of novel lipid-lowering agents.